Streetbeat News

Revenues

ACB

Aurora Cannabis Inc. (NASDAQ:ACB) has been granted two licenses by Germany's Federal Institute for Drugs and Medical Devices, allowing it to expand its medical cannabis production and research in Germany. The company plans to cultivate additional products and trial new cultivars, positioning itself to capture a significant share of the growing German cannabis market.

Portfolio Pulse from Jelena Martinovic

July 26, 2024 | 3:06 am

CMCSA

DKNG

EWJ

EWZ

FXI

SPY

The article examines the impact of the Summer Olympics on the stock market, highlighting that while the games can cause volatility for companies directly tied to the event, such as Comcast Corp (NASDAQ:CMCSA), the overall market impact is minimal. The SPDR S&P 500 ETF Trust (NYSE:SPY) has shown modest gains during past Olympics. Country-specific ETFs like iShares MSCI Japan Fund (NYSE:EWJ), iShares MSCI Brazil ETF (NYSE:EWZ), and iShares China Large-Cap ETF (NYSE:FXI) have had mixed results. DraftKings Inc (NASDAQ:DKNG) is also mentioned for its odds on medal counts.

Portfolio Pulse from Chris Katje

July 25, 2024 | 10:24 pm

ORC

Orchid Island Capital (NYSE: ORC) reported a Q2 2024 adjusted EPS of $(0.09), missing the $(0.07) estimate, but reported sales of $(697.000K), beating the $(2.945M) estimate. Sales increased by 92.04% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:14 pm

NOV

NOV has revised its FY24 consolidated company revenue growth forecast to a low- to mid-single digit percent range, down from the prior mid-single percentage range. The company also adjusted its full-year 2024 Adjusted EBITDA forecast to $1.10 billion to $1.18 billion, from the previous range of $1.10 billion to $1.25 billion.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:07 pm

NOV

NOV expects Q3 consolidated revenues to be flat to up in the low-single digit percent range. Management anticipates Adjusted EBITDA to be between $270 million and $305 million.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:03 pm

NOV

NOV (NYSE:NOV) reported Q2 2024 earnings of $0.57 per share, significantly beating the analyst estimate of $0.35. Sales also surpassed expectations, coming in at $2.216 billion versus the $2.193 billion estimate. Both earnings and sales showed notable year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:01 pm

CTO

CTO Realty Growth (NYSE:CTO) reported Q2 2024 earnings per share of $0.48, surpassing the analyst estimate of $0.39 by 23.08%. The company also reported sales of $28.845 million, beating the estimate of $27.411 million by 5.23%. This marks a 10.74% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:01 pm

PFS

Provident Financial Services (NYSE:PFS) reported Q2 2024 adjusted EPS of $0.10, missing the analyst estimate of $0.35 by 71.43%. However, the company reported sales of $141.506 million, beating the estimate of $118.545 million by 19.37%. This represents a 19.42% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 9:58 pm

ZBAO

Zhibao has entered into a strategic investment cooperation with Sport Covers to develop a new business model in digital sports and insurance brokerage. The partnership is expected to significantly boost Zhibao's revenue over the next few years, with projected increases of CNY 20M in 2024, CNY 50M in 2025, and CNY 80M in 2026. Zhibao aims to capture a substantial share of the sports-related insurance market, targeting 10% by 2024, over 15% by 2025, and more than 20% by 2026.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 9:38 pm